Search results
Showing 61 to 70 of 70 results for glaucoma
Trabeculectomy with a biodegradable collagen matrix implant for glaucoma (IPG750)
We have moved interventional procedures guidance 750 to become HealthTech guidance 656. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Ab externo canaloplasty for primary open-angle glaucoma (IPG591)
We have moved interventional procedures guidance 591 to become HealthTech guidance 448. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Trabecular stent bypass microsurgery for open-angle glaucoma (IPG575)
We have moved interventional procedures guidance 575 to become HealthTech guidance 432. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Trabecular stent bypass microsurgery for open angle glaucoma (IPG396)
This guidance has been updated and replaced by NICE interventional procedure guidance 575.
Benralizumab for treating severe eosinophilic asthma (TA565)
Evidence-based recommendations on benralizumab (Fasenra) for treating severe eosinophilic asthma in adults.
Evidence-based recommendations on tezepelumab (Tezspire) for treating severe asthma in people 12 years and over.
Insertion of an epiretinal prosthesis for retinitis pigmentosa (HTG372)
Evidence-based recommendations on insertion of an epiretinal prosthesis for retinitis pigmentosa. This involves inserting an implant into the eye that receives data from a small camera on the person's glasses and then stimulates healthy cells in the retina to see basic images.
We have moved interventional procedures guidance 612 to become HealthTech guidance 470. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
This guideline covers mid-life approaches to delay or prevent the onset of dementia, disability and frailty in later life. The guideline aims to increase the amount of time that people can be independent, healthy and active in later life.
This manual explains the processes and methods used to develop and update NICE guidelines, the guidance that NICE develops covering topics across clinical care (in primary, secondary and community care settings), social care and public health. For more information on the other types of NICE guidance and advice (including technology appraisal guidance), see about NICE